Why is Jiangsu Sihuan Bioengineering Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 0.40%
- The company has been able to generate a Return on Capital Employed (avg) of 0.40% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -10.27% and Operating profit at -214.16% over the last 5 years
3
With a growth in Net Sales of 215.13%, the company declared Very Positive results in Mar 25
- The company has declared positive results in Jan 70 after 2 consecutive negative quarters
- DEBTORS TURNOVER RATIO(HY) Highest at 2.69%
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -18.77%, its profits have fallen by -116.7%
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -18.77% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to Jiangsu Sihuan Bioengineering Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Jiangsu Sihuan Bioengineering Co., Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Jiangsu Sihuan Bioengineering Co., Ltd.
-31.54%
0.38
50.16%
China Shanghai Composite
15.19%
1.01
15.10%
Quality key factors
Factor
Value
Sales Growth (5y)
-10.27%
EBIT Growth (5y)
-214.16%
EBIT to Interest (avg)
-20.68
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
0.50
Tax Ratio
0.71%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.40%
ROE (avg)
0.14%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
6.41
EV to EBIT
-26.55
EV to EBITDA
-32.15
EV to Capital Employed
7.03
EV to Sales
8.19
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-26.49%
ROE (Latest)
-31.13%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Technical Movement
1What is working for the Company
DEBTORS TURNOVER RATIO(HY)
Highest at 2.69%
-23What is not working for the Company
NET PROFIT(HY)
At CNY -111.31 MM has Grown at -218.56%
INTEREST(9M)
At CNY 2.03 MM has Grown at 10.31%
ROCE(HY)
Lowest at -29.46%
CASH AND EQV(HY)
Lowest at CNY 20.17 MM
NET SALES(Q)
Lowest at CNY 43.64 MM
Here's what is working for Jiangsu Sihuan Bioengineering Co., Ltd.
Debtors Turnover Ratio
Highest at 2.69%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Jiangsu Sihuan Bioengineering Co., Ltd.
Net Profit
At CNY -111.31 MM has Grown at -218.56%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Net Sales
At CNY 43.64 MM has Fallen at -13.62%
over average net sales of the previous four periods of CNY 50.52 MMMOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Interest
At CNY 2.03 MM has Grown at 10.31%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Sales
Lowest at CNY 43.64 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Cash and Eqv
Lowest at CNY 20.17 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents






